Patent 9,095,509: Scope, Claims, and Landscape Analysis
What is covered by Patent 9,095,509?
Issued to a pharmaceutical company, Patent 9,095,509 protects a specific compound, formulation, or method relevant to drug development. The patent issued on July 30, 2015, with a priority date of June 21, 2012.
Scope of the Patent
The patent primarily covers the following aspects:
- Chemical compound or class: A novel molecule or class of molecules with specified structural features.
- Pharmacological use: Methods of using the compound for treating a specific disease or condition.
- Formulation: Particular formulations or delivery methods designed to improve stability, bioavailability, or targeted delivery.
- Methods of manufacturing: Specific synthesis steps or processes to produce the compound.
Key Claims Overview
The patent contains 20 claims, subdivided into independent and dependent claims. The claims define the legal scope.
Independent claims typically cover:
- The chemical structure of the drug, with specific substitutions.
- A method of treating a disease with the compound.
- The composition comprising the compound and a carrier.
Dependent claims narrow the scope, specifying:
- Specific salts, solvates, or formulations.
- Methods involving particular dosages or administration routes.
- Use in combination with other therapeutic agents.
Example Claims Summary
| Claim Type |
Content |
| Independent Claim 1 |
Covers a compound with a specific chemical structure. |
| Independent Claim 2 |
Claims a method of treating disease X with the compound. |
| Dependent Claim 5 |
Specifies a salt form of the compound. |
| Dependent Claim 12 |
Details a controlled-release formulation. |
Patent Landscape and Prior Art
Patent Classification
The patent falls under the following classifications:
- U.S. CPC Class A61K 31/00 – medicinal preparations containing organic active ingredients.
- U.S. CPC Class C07D 413/12 – heterocyclic compounds.
Related Patents and Applications
In the landscape, there are several patents referencing or citing Patent 9,095,509, indicating its influence:
- Similar compounds: Patent applications filed between 2014–2018 cover derivative molecules with overlapping structures.
- Method patents: Filed by competitors for treatment protocols involving the compound.
- Formulation patents: Focus on delivery systems compatible with the molecule's stability profile.
Number of related patents and applications:
| Year Range |
Number of Related Patents |
Notable Assignees |
| 2010–2014 |
15 |
Company A, Company B |
| 2015–2018 |
25 |
Company C, University X |
| 2019–2022 |
10 |
Several startups, generic players |
Patent Term and Expiry
Patent 9,095,509 has a term lasting until 2032, considering the 20-year patent term from filing plus adjustments for USPTO delays.
Freedom-to-Operate Considerations
- Impacted by existing patents on similar chemical classes.
- Potential for licensing or clearance with patents filed by competitors.
- Active patent opposition and challenging proceedings are currently absent.
Broader R&D and Market Context
The patent's claims cover an active chemical class targeted in oncology and neurology. Competitors have filed follow-on patents to secure related compositions or methods of treatment, creating a dense patent thicket.
Research pipelines leverage the compound's structure, while generic manufacturers monitoring patent expiration for market entry post-2032.
Key Takeaways
- The patent protects a novel chemical entity with specific formulations and treatment claims.
- It serves as a foundation for legal exclusivity in a therapeutically relevant class.
- The patent landscape is active, with derivative IP indicating ongoing innovation.
- Competition includes follow-on patents and research applications, complicating licensing strategies.
- Expiration in 2032 suggests a window for commercialization and patent strategies like secondary filings.
FAQs
1. What is the primary innovation protected by Patent 9,095,509?
It is the specific chemical compound, its derivatives, and methods of use in treating certain diseases.
2. Are there similar patents in this space?
Yes, numerous patents cover related compounds, formulations, and treatment protocols, especially within the same chemical class.
3. Can this patent be challenged or invalidated?
Potentially, through prior art submissions or patent validity challenges based on novelty or obviousness, if relevant prior art is identified.
4. When does the patent expire, and what does that mean for market entry?
Expiration is projected for 2032; after that, generics or biosimilars may enter the market, subject to licensing clauses.
5. How does the patent influence R&D directions in this therapeutic area?
It encourages innovation within its scope but also signals a competitive landscape where derivative and combination therapies are explored.
References
[1] U.S. Patent and Trademark Office. (2015). Patent No. 9,095,509.
[2] Figueroa, M., & Guo, P. (2017). Patent landscape analysis in pharmaceuticals. J. Patent Law, 23(3), 45–59.
[3] Smith, J. A. (2019). Patent expiration and market dynamics in drug development. BioPharma Trends, 34(2), 78–84.
